Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.34 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.33 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.33 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 3/20 | 0.32 |
| ▸ | SMPD3 | Q9NY59 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.30 |
| ▸ | ADK | P55263 | 1/20 | 0.30 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11334976 | 0.88 | ALDH1A1 (0.44) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL7766524 | 0.86 | ALDH1A1 (0.41) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL3995849 | 0.86 | TBXAS1 (0.37) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| Hydrochloric Acid SCHEMBL2493637 | 0.84 | ALDH1A1 (0.40) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL9063985 | 0.84 | ALDH1A1 (0.40) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL667770 | 0.84 | — | — | |
| SCHEMBL2565429 | 0.83 | ALDH1A1 (0.40) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL11335584 | 0.83 | ALDH1A1 (0.34) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL145933 | 0.83 | — | — | |
| SCHEMBL22404 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 391 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3687652-B1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER FOR RETENTION OF ACIDIC ANALYTES | WATERS TECHNOLOGIES CORP (US) | 2025-07-09 | — | — | EP | claimed |
| US-12252557-B2 | Charged surface reversed phase chromatographic materials method for analysis of glycans modified with amphipathic, strongly basic moieties | WATERS TECHNOLOGIES CORPORATION (US) | 2025-03-18 | — | — | US | claimed |
| CN-110249052-B | Synthetic guide molecules, compositions, and methods related thereto | 爱迪塔斯医药公司 | 2024-04-12 | — | — | CN | claimed |
| CN-117500817-A | Peptides comprising phosphorylcholine conjugates and methods of synthesizing the same | 塔西亚制药公司 | 2024-02-02 | — | — | CN | claimed |
| CN-117054585-A | Charged surface reversed phase chromatography material method for analysis of glycans modified with amphiphilic strong basic moieties | 沃特世科技公司 | 2023-11-14 | — | — | CN | claimed |
| CN-109154604-B | Charged surface reversed phase chromatography material method for analysis of glycans modified with amphiphilic strong basic moieties | 沃特世科技公司 | 2023-07-21 | — | — | CN | claimed |
| EP-4129466-A1 | HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | Waters Technologies Corporation (US) | 2023-02-08 | — | — | EP | claimed |
| CN-112321399-B | Preparation method of chemical intermediate | 漯河豫博生物化工有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-114524812-A | Crystal form preparation and synthesis method of 1, 4-dihydro-1, 6-naphthyridine compound | 湖南凯铂生物药业有限公司 | 2022-05-24 | — | — | CN | claimed |
| CN-112299968-B | Preparation method of chemical raw material | 广州彼西络科技有限公司 | 2022-05-06 | — | — | CN | claimed |
| US-20050038256-A1 | Synthetic process for trans-aminocyclohexyl ether compounds | CARDIOME PHARMA CORP. (CA) | 2005-02-17 | — | — | US | claimed |
| US-20030180804-A1 | Solid phase synthesis of chemical libraries | CORVAS INTERNATIONAL, INC | 2003-09-25 | — | — | US | claimed |
| WO-2003037326-A1 | SOLID PHASE SYNTHESIS OF CHEMICAL LIBRARIES | CORVAS INTERNATIONAL, INC. (US) | 2003-05-08 | — | — | WO | claimed |
| EP-1209205-A1 | Improved process and method for the preparation of asymetric monofunctionalised indocyanine labelling reagents and obtained compounds | Innosense S.r.l. (IT) | 2002-05-29 | — | — | EP | claimed |
| EP-0923566-A4 | HIGH MOLECULAR WEIGHT POLYMER-BASED PRODRUGS | ENZON INC (US) | 2001-10-10 | — | — | EP | claimed |
| JP-2000517304-A | — | — | 2000-12-26 | — | — | JP | claimed |
| US-6011042-A | POLYMERIC PRODRUGS ARE PREFERABLY ESTERS OF HYDROXYL-CONTAINING AROMATIC COMPOUNDS AND ARE FORMED BY REACTING A DESIRED AROMATIC, HYDROXYL-CONTAINING COMPOUND WITH A SUBSTANTIALLY NON-ANTIGENIC POLYMER | ENZON, INC. (US) | 2000-01-04 | — | — | US | claimed |
| US-5965566-A | A WATER SOLUBLE BIOLOGICAL ACTIVE DRUG CONJUGATED WITH POLYOXYETHYLENE GLYCOL THROUGH A HYDROLYZABLE ESTER LINKAGING SPACER; CONTROLLED RELEASE PROPERTIES | ENZON, INC. (US) | 1999-10-12 | — | — | US | claimed |
| EP-0923566-A1 | HIGH MOLECULAR WEIGHT POLYMER-BASED PRODRUGS | ENZON, INC. (US) | 1999-06-23 | — | — | EP | claimed |
| WO-1998007713-A1 | HIGH MOLECULAR WEIGHT POLYMER-BASED PRODRUGS | ENZON, INC. (US) | 1998-02-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030180804-A1 | Solid phase synthesis of chemical libraries | PEPD, DNPEP, PRSS1 | ALDH1A1 3434/4885KDM4E 2571/4885SMN1; SMN2 3967/4885 |
| US-20050038256-A1 | Synthetic process for trans-aminocyclohexyl ether compounds | AKR1C3, CBR1, CBR3 | ALDH1A1 1484/4885KDM4E 3727/4885SMN1; SMN2 4168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.